What are NVAX's recent SEC filings?
State Street Corporation filed a Schedule 13G disclosing beneficial ownership of 8,827,707 shares (5.4%) of Novavax Inc common stock as of September 30, 2026, held in the ordinary course of business as a passive investor.
View full filing details →Novavax filed its Q3 2026 Form 10-Q for the period ended September 30, 2026, reporting quarterly financial results including product revenue and licensing/royalty revenue.
View full filing details →Novavax, Inc. filed a Form 8-K on November 5, 2026, announcing its financial results for the third quarter ended September 30, 2026, via an attached press release.
View full filing details →Novavax filed a routine Form 8-K cover page with the SEC on October 29, 2026, containing only standard registrant identification and XBRL metadata with no substantive corporate event disclosed.
View full filing details →A Schedule 13G filing was submitted regarding Novavax Inc (NVAX), indicating a passive ownership position by an institutional or other holder. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
View full filing details →An amendment to a Schedule 13D was filed regarding Novavax Inc, indicating a change in a major shareholder's ownership position or intentions. The filing text provided is only a directory listing and does not contain the substantive details of the amendment.
View full filing details →Has NVAX ever done a stock split?
What is NVAX's share float?
Get Real-Time NVAX Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free